background
tonsil
provid
innov
vivo
model
investig
immun
respons
infect
allergen
howev
data
scarc
differ
tonsillar
viru
infect
immun
respons
patient
tonsillar
hypertrophi
recurr
tonsil
investig
differ
viru
detect
cell
interferon
gene
express
patient
undergo
tonsillectomi
due
tonsillar
hypertrophi
recurr
tonsil
method
tonsil
surgic
patient
tonsillar
hypertrophi
n
recurr
tonsil
n
analys
patient
care
character
clinic
standard
questionnair
use
ass
preced
allergi
symptom
respiratori
virus
analys
tonsil
nasopharynx
pcr
quantit
realtim
pcr
use
analys
intratonsillar
gene
express
tbet
result
median
age
subject
year
rang
patient
tonsillar
hypertrophi
younger
smoke
less
often
less
pollen
allergi
adenoviru
coronaviru
rhinoviru
nasopharynx
p
often
detect
hypertroph
tonsil
p
ageadjust
analysi
tonsillar
hypertrophi
associ
higher
mrna
express
p
conclus
intratonsillar
cell
interferon
gene
express
appear
rel
stabl
tonsillar
hypertrophi
recurr
tonsil
studi
cytokin
newli
discov
antiinflammatori
cytokin
independ
associ
tonsillar
hypertrophi
show
slightli
stronger
antiinflammatori
respons
patient
permit
unrestrict
use
distribut
reproduct
medium
provid
give
appropri
credit
origin
author
sourc
provid
link
creativ
common
licens
indic
chang
made
creativ
common
public
domain
dedic
waiver
http
creat
iveco
mmon
org
publi
cdoma
appli
data
made
avail
articl
unless
otherwis
state
sampl
clinic
data
collect
tp
ms
li
tonsillar
diseas
one
common
disord
field
otorhinolaryngolog
differ
type
tonsillar
diseas
includ
recurr
tonsil
tonsillar
hypertrophi
lead
symptom
mouth
breath
snore
dyspnea
apnea
dysphagia
treatment
usual
antibiot
tonsillectomi
tonsil
secondari
lymphoid
organ
central
locat
begin
respiratori
gastrointestin
tract
immun
system
first
come
contact
infect
agent
allergen
surgic
remov
palatin
tonsil
provid
convent
access
sourc
studi
interplay
foreign
pathogen
allergen
host
immun
system
previou
studi
demonstr
tonsil
organ
immun
regul
take
clinic
translat
allergi
correspond
tuomasjartti
utufi
varpu
eleniu
maria
saarinen
contribut
equal
second
author
depart
paediatr
adolesc
medicin
turku
univers
hospit
turku
univers
po
box
turku
finland
full
list
author
inform
avail
end
articl
place
allergenspecif
regulatori
cell
gener
mechan
depend
plasmacytoid
dendrit
cell
express
celland
interferon
specif
gene
tonsil
shown
close
relat
exist
viral
infect
age
allerg
ill
howev
data
scarc
differ
tonsillar
viru
infect
immun
respons
patient
tonsillar
hypertrophi
recurr
tonsil
tonsil
appear
provid
good
vivo
model
investig
mechan
inflammatori
process
infect
lymphoid
organ
therefor
studi
whether
viru
detect
cell
interferon
gene
express
differ
two
main
indic
surgeri
tonsillar
hypertrophi
recurr
tonsil
human
tonsil
sampl
use
studi
acquir
consecut
tonsillectomi
patient
underw
tonsillectomi
satakunta
central
hospit
pori
finland
april
march
inclus
criteria
elect
tonsillectomi
accord
clinic
indic
written
inform
consent
studi
patient
andor
hisher
guardian
studi
protocol
approv
ethic
committe
satakunta
central
hospit
pori
finland
studi
initi
obtain
written
consent
particip
hisher
guardian
standard
questionnair
use
obtain
inform
allerg
diseas
respiratori
symptom
within
day
oper
addit
file
tabl
tonsillectomi
perform
accord
routin
clinic
procedur
intern
tonsillar
tissu
immedi
cut
mm
cube
store
rnalat
rna
stabil
reagent
qiagen
hilden
germani
incub
next
work
day
final
store
remov
nonabsorb
reagent
viral
analys
part
tonsil
nasopharyng
aspir
store
dri
tube
nasopharyng
aspir
sampl
obtain
anaesthesia
use
standard
procedur
serum
total
oh
measur
done
use
immunoassay
abbott
architect
chicago
usa
bioavail
level
oh
estim
use
addit
serum
measur
dbind
protein
albumin
publish
formula
tonsillar
hypertrophi
group
defin
patient
underw
tonsillectomi
obstruct
symptom
snore
breath
difficulti
swallow
problem
tonsillar
infect
problem
group
recurr
tonsil
group
defin
patient
underw
tonsillectomi
recurr
infect
tonsil
viral
bacteri
past
month
oper
acut
infect
peritonsillar
abscess
exclud
inhous
realtim
pcr
assay
use
detect
human
rhinoviru
enteroviru
respiratori
syncyti
viru
describ
previous
seeplex
ace
detect
seegen
seoul
korea
multiplex
pcr
assay
use
detect
adenoviru
coronavirus
influenza
b
virus
metapneumoviru
parainfluenza
viru
type
respiratori
syncyti
viru
group
b
rhinoviru
viru
diagnost
carri
depart
virolog
univers
turku
turku
finland
depart
clinic
microbiolog
karolinska
univers
hospit
stockholm
sweden
isol
total
rna
palatin
tonsil
tissu
previous
stabil
rnalat
homogen
grind
tube
contain
ceram
bead
use
precelli
homogen
bertin
technolog
montigni
le
bretonneux
franc
two
time
rpm
total
rna
cell
sampl
isol
use
rneasi
mini
kit
qiagen
hilden
germani
revers
transcript
perform
revert
aid
mmulv
revers
transcriptas
fermenta
st
leonrot
germani
use
random
hexam
primer
accord
manufactur
protocol
gene
express
tbet
analys
quantit
realtim
pcr
use
itaq
sybr
green
supermix
rox
biorad
hercul
ca
usa
fast
realtim
pcr
instrument
appli
biosystem
foster
citi
ca
usa
housekeep
gene
elong
factor
use
normal
data
shown
rel
express
show
valu
multipli
correspond
differ
ct
valu
gene
interest
continu
variabl
describ
median
interquartil
rang
analys
use
mannwhitney
u
test
due
skew
distribut
categor
variabl
express
frequenc
percentag
analys
use
chi
squar
test
fisher
exact
test
clinic
viral
immunolog
differ
studi
group
analys
use
unadjust
multivari
linear
regress
analysi
adjust
immunolog
analys
chosen
use
backward
stepwis
multivari
model
initi
includ
clinic
factor
viru
infect
significantli
differ
group
age
selfreport
pollen
allergi
selfsmok
adenotomi
tonsillectomi
perform
respiratori
symptom
one
month
prior
oper
bioavail
oh
level
final
model
adjust
age
regress
analys
cytokin
transcript
factor
valu
logtransform
posit
skew
distribut
mean
differ
comput
logtransform
valu
recurr
infect
group
minu
hypertroph
group
statist
analysi
complet
use
jmp
version
softwar
sa
institut
inc
cari
nc
usa
twosid
p
consid
statist
signific
origin
patient
particip
studi
subject
remain
tonsil
nasopharyng
sampl
current
analysi
intratonsillar
virolog
done
sampl
anoth
subject
exclud
mix
indic
oper
hypertrophi
tonsil
fig
thu
patient
compris
analyt
cohort
fortyseven
tonsillar
hypertrophi
recurr
tonsil
oper
perform
afebril
period
chronic
tonsil
condit
respiratori
symptom
oper
day
present
equal
hypertrophi
group
recurr
tonsil
group
vs
respect
p
median
age
patient
year
rang
year
rang
respect
p
tabl
addit
younger
patient
hypertrophi
group
often
adenotomi
tonsillectomi
done
hypertrophi
anoth
indic
recurr
otiti
media
n
recurr
otiti
media
fever
n
recurr
fever
n
recurr
tonsil
anoth
indic
recurr
fever
n
recurr
otiti
media
n
hypertrophi
tonsil
hypertrophi
tonsil
anoth
indic
recurr
fever
n
recurr
otiti
media
recurr
fever
n
recurr
otiti
media
n
less
selfreport
pollen
allergi
smoke
less
less
throat
pain
often
rhiniti
cough
month
prior
oper
higher
bioavail
oh
level
patient
recurr
tonsil
group
p
tabl
otherwis
signific
differ
found
two
group
significantli
patient
hypertrophi
group
compar
recurr
tonsil
group
viru
nasopharyng
aspir
vs
respect
p
addit
patient
hypertrophi
group
often
adenoviru
coronaviru
rhinoviru
nasopharyng
aspir
p
tabl
howev
intratonsillar
viru
detect
nt
show
statist
signific
differ
except
detect
tonsil
patient
hypertrophi
patient
recurr
tonsil
group
tabl
patient
hypertrophi
group
often
posit
one
viru
nasopharyng
aspir
vs
two
virus
tonsil
vs
respect
p
tabl
unadjust
analysi
patient
hypertrophi
group
stronger
tonsillar
express
tbet
p
p
patient
recurr
tonsil
group
tabl
multivari
regress
analysi
age
remain
signific
cofactor
tabl
adjust
age
express
independ
associ
tonsillar
hypertrophi
group
p
fig
differ
cytokin
transcript
factor
express
found
group
studi
show
differ
viru
detect
cell
interferon
gene
express
patient
undergo
tonsillectomi
due
tonsillar
hypertrophi
recurr
tonsil
patient
tonsillar
hypertrophi
typic
younger
viral
find
often
found
tonsil
compar
patient
recurr
tonsil
respect
also
less
selfreport
pollen
allergi
differ
found
food
allergi
group
ageadjust
analysi
tonsillar
hypertrophi
associ
higher
tonsillar
mrna
express
age
signific
cofactor
found
formerli
famili
member
fundament
inhibitor
innat
immun
shown
express
macrophag
monocyt
plasma
epitheli
cell
ligand
activ
inhibit
inflammatori
cytokin
especi
also
augment
level
antiinflammatori
regulatori
cell
previous
shown
express
close
posit
associ
immun
activationregulatori
cytokin
tbet
tonsil
current
analysi
add
tonsillar
express
antiinflammatori
cytokin
also
independ
posit
associ
tonsillar
hypertrophi
interferon
cytokin
antivir
activ
express
induc
viral
infect
member
famili
produc
dendrit
data
express
mean
differ
recurr
infect
group
minu
hypertroph
group
data
analys
use
backward
stepwis
linear
regress
analysi
logarithm
transform
signific
cofactor
use
adjust
final
model
expect
see
differ
ifn
express
lower
respons
recurr
tonsil
tonsillar
hypertophi
group
sinc
antivir
properti
upregul
express
mhc
class
ii
molecul
cell
increas
immun
system
abil
recogn
virus
howev
observ
differ
specul
tonsillar
hypertophi
may
consequ
chronic
inflamm
tonsil
interferon
pathway
equal
activ
condit
previous
found
strong
intragroup
correl
tonsillar
ifn
express
age
main
clinic
characterist
differenti
tonsillectomi
indic
group
agreement
previou
find
found
obstruct
due
hypertrophi
common
younger
children
adult
recurr
tonsil
age
differ
group
also
explain
differ
smoke
addit
adenotomi
perform
interestingli
rei
colleagu
found
differ
age
distribut
hypertrophi
tonsil
patient
narrow
age
rang
subject
age
year
may
explain
lack
differ
viru
found
nasopharynx
patient
tonsillar
hypertrophi
group
recurr
tonsil
group
often
detect
virus
adenoviru
coronaviru
rhinoviru
howev
intratonsillar
viru
detect
low
show
statist
signific
differ
except
result
nasopharyng
intratonsillar
viru
detect
vs
tonsillar
cytokin
respons
discuss
detail
previou
report
small
differ
cytokin
express
may
partli
explain
differ
concern
tonsillar
germin
center
mean
follicular
area
found
larger
number
germin
center
higher
hypertrophi
group
compar
recurr
tonsil
studi
sampl
taken
insid
tonsil
minim
margin
error
possibl
misinterpret
differ
group
season
chang
eg
pollen
influenza
season
may
affect
express
peripher
cell
found
differ
tonsillar
express
cytokin
season
surgeri
also
respiratori
virus
continu
detect
children
chronic
tonsil
throughout
year
circul
serum
oh
level
shown
posit
associ
level
confound
result
limit
current
studi
investig
bacteri
colon
tonsil
patient
due
fact
oper
done
afebril
period
chronic
tonsil
condit
downstream
signal
complex
process
show
function
downstream
mediat
scope
studi
addit
form
cellsurfac
receptor
complex
transloc
nucleu
bind
nuclear
dna
particip
transcript
regard
dual
function
cytokin
similar
summari
studi
provid
new
insight
cell
research
lymphoid
tissu
clinic
aspect
surgic
indic
tonsillectomi
found
tonsil
good
vivo
model
investig
mechan
inflammatori
process
infect
lymphoid
organ
data
suggest
tcell
interferon
gene
express
appear
rel
stabl
two
main
indic
tonsillectomi
tonsillar
hypertrophi
recurr
tonsil
howev
antiinflammatori
immun
respons
name
might
slightli
stronger
patient
tonsillar
hypertrophi
patient
recurr
tonsil
addit
file
health
questionnair
